Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardiol Therapeutics Inc. - Class A Common Shares (NQ:CRDL)

1.355 +0.045 (+3.44%)
Streaming Delayed Price Updated: 11:22 AM EDT, Apr 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardiol Therapeutics Inc. - Class A Common Shares

< Previous 1 2 Next >
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
3 Penny Stocks Ready to Break Out in 2025
Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products. 
Via MarketBeat
News headline image
CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study ↗
 
Via Benzinga
News headline image
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today ↗
Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... 
Via Benzinga
News headline image
AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday ↗
 
Via Benzinga
News headline image
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024 ↗
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients 
Via News Direct
News headline image
Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics
Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics 
Via News Direct
News headline image
CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024 ↗
CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In ↗
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. 
Via Benzinga
Topics Cannabis
News headline image
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023 ↗
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Cardiol Therapeutics - This Penny Stock Is An Analysts Favorite ↗
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies. 
Via Talk Markets
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
--News Direct-- 
Via News Direct
Topics Death
News headline image
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations ↗
697,000 people die from heart disease every year in the United States – that is one in every five deaths. 
Via Benzinga
News headline image
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects ↗
On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in... 
Via Benzinga
News headline image
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket ↗
Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  During Tuesday's session, 78 companies made new 52-week lows. 
Via Benzinga
News headline image
FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis ↗
The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) from Cardiol Therapeutics Inc. (NASDAQ: CRDL) to start a Phase 2 open-label pilot study designed... 
Via Benzinga
News headline image
76 Biggest Movers From Yesterday ↗
Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to... 
Via Benzinga
News headline image
34 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.... 
Via Benzinga
News headline image
68 Biggest Movers From Yesterday ↗
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022 ↗
Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,... 
Via Benzinga
News headline image
51 Biggest Movers From Thursday ↗
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of... 
Via Benzinga
News headline image
Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial ↗
The FDA and regulatory agencies in Brazil & Mexico have cleared Cardiol Therapeutics Inc (NASDAQ: CRDL) to modify the inclusion criteria for the LANCER trial to... 
Via Benzinga
News headline image
52 Biggest Movers From Yesterday ↗
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G... 
Via Benzinga
News headline image
65 Biggest Movers From Yesterday ↗
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.